FDA Warns Drug & Device Firms Against Delaying & Limiting Facility Inspections in New Draft Guidance | King & Spalding
On December 16, 2022, the U.S. Food & Drug Administration (“FDA” or “Agency”) published an important and noteworthy draft guidance document entitled “Circumstances that Constitute...
Source: jdsupra.com
